CVE-2023-1006 json
SourceCodester Medical Certificate Generator App New Record cross site scripting
published 2023-02-24 3 y ago modified 2026-06-17 4 mo ago also EUVD-2023-23298
- cvss
- 3.5
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 18%
- public exploits
- 0
- none known
Summary
A vulnerability was found in SourceCodester Medical Certificate Generator App 1.0. It has been classified as problematic. This affects an unknown part of the component New Record Handler. The manipulation of the argument Firstname/Middlename/Lastname/Suffix/Nationality/Doctor Fullname/Doctor Suffix with the input "><script>prompt(1)</script> leads to cross site scripting. It is possible to initiate the attack remotely. The associated identifier of this vulnerability is VDB-221739.
CISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- 19 mo ago
Exploit prediction
0.26% chance of exploitation in the next 30 days, higher than 18% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 3.5 | CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N |
| CNA | 3.0 | 3.5 | CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N |
| CNA | 2.0 | 4.0 | AV:N/AC:L/Au:S/C:N/I:P/A:N |
| NVD | 3.1 | 5.4 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N |
Affected products
- SourceCodester Medical Certificate Generator App
Classification
- Weakness
-
- CWE-79 Improper Neutralization of Input During Web Page Generation
References
-
vuldb.com
/?id.221739
vdb-entry, technical-description, permissions-required, third-party-advisory
-
vuldb.com
/?ctiid.221739
signature, permissions-required, third-party-advisory, vdb-entry
Sources
- CVE List CVE-2023-1006
- NVD CVE-2023-1006
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.